Lawyers Review Claims for SSRI Birth Defects
As the number of SSRI birth defect lawsuits climbs to the point that hundreds are being consolidated in a massive class action in the...
âAntipsychotics During Pregnancy Not Tied to Birth Defectsâ
The New York Times Well blog reports on a new study, in JAMA Psychiatry, which found that antipsychotic medicines during pregnancy do not increase the...
2X Risk of Postpartum Hemorrhage Antidepressants
A study of 106,000 pregnant women with a diagnosis of mood or anxiety disorder, by researchers from Harvard, Duke, Michigan State and the university...
How the Same Study with Different Conclusions Could Spell Disaster for Unborn and New-Born...
Last year (2012) the British Medical Journal (BMJ) published a study from 5 Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) based on more...
“Prescription Drugs Lead to Growing Problem of Infant Addiction”
Ten years ago, infants born with drug addictions was associated with street drugs. But the rise of prescription drug addiction in the past ten...
âThe Rise and Fall of the Blockbuster Antipsychotic Seroquelâ
Martha Rosenberg highlights how the popular antipsychotic Seroquel is a perfect example of how direct-to-consumer advertising made billion dollar blockbuster drugs possible before side-effects...
âWhy did Thalidomideâs Makers Ignore Warnings About Their Drug?â
Sociologist Garry Gray examines the institutional pressures and systemic failings that allow unsafe drugs to hit the market. âResearch integrity and the institutional structures that support scientific research are key to understanding and eliminating scientific compromises. Without this understanding, we canât truly progress beyond the 'GrĂŒnenthal science' that underscored the thalidomide tragedy.â
Increased Risk of Preterm Birth in Women Taking Antidepressants
A detailed meta-analysis of the published research on women taking antidepressants during pregnancy finds that the rate of preterm birth is nearly doubled in the third...
Are Drug Companies Grooming New Customers in the Womb?
From The Baltimore Sun: Over time, studies have shown that antidepressants during pregnancy are linked with congenital defects as well as increased incidence of depression...
âNew Pill for Boosting Female Libidos Off to a Slow Startâ
Ed Silverman reports that only 80 prescriptions for Addyi, or Flibanserin, were filled in the drugsâ first two weeks on the market.
Article â
âPunish People, Not Just Corporationsâ
Drug makers have faced large fines for unethical and harmful practices but have simply treated these as a cost of doing business. Ed Silverman reports...
Despite Risks, Antidepressant Use among Reproductive Age Women Increases
Accumulating evidence points to serious risks associated with antidepressant use during pregnancy, yet data suggests that prescriptions continue to rise in the US. "Given...
âFDA Forced to Release Adverse Event Reports on Psychiatric Drugsâ
Following a lawsuit brought by Andrew Thibault of Parents Against Pharmaceutical Abuse (PAPA), the FDA has produced adverse event and severe adverse event reports...
Prenatal Valproate Exposure Linked with ADHD Diagnosis in Children
Children who were exposed to anti-seizure drug valproate in utero were 48% more likely to develop ADHD, according to a new study.
Moms Reach $6.2-million Settlement in Paxil Lawsuit
From The Province: Mothers alleging that taking Paxil during pregnancy caused heart problems for their children have reached a settlement of $6.2-million with GlaxoSmithKline U.K.
Article...
Antidepressants and Withdrawal: Readers Tell Their Stories
More than 8,000 people responded to the recent New York Times article on antidepressant withdrawal. Here, reporter Benedict Carey describes differences in the way various...
âWoman Wins Epilepsy Drug Warning Fightâ
A UK mother has won a three-year battle to have warning labels put on epilepsy drugs which cause birth defects, heart problems, and learning disabilities.
First Federal Zoloft Birth Defect Trial Scheduled
In a bellwether case, plaintiffs allege that Pfizer did not adequately warn patients that Zoloft (sertraline) would cause birth defects. The case is scheduled in Federal Court in March, and the verdict will have significant implications for future suits.